Nasdaq

Arcutis : ZORYVE Cream 0.15% Improves Atopic Dermatitis Across Skin Types In Phase 3 Trials

(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...
Healio

Gene expression analysis effective in melanoma detection in skin of color

Please provide your email address to receive an email when new articles are posted on . Noninvasive gene expression testing by DermTech detects melanoma equally in all Fitzpatrick skin types. The test ...